CNW/ -- (OTCQX: NDOI) announced today the launch of a Spatial Computing Injection Simulator for Peyronie's disease. The ...

AbbVie  today announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trenibotulinumtoxinE (TrenibotE) for the treatment of moderate to severe ...

The UK medicines regulator has approved Pfizer’s marstacimab for patients aged 12 years or older with severe haemophilia A or B, offering a new subcutaneous treatment option.

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

Ferring Pharmaceuticals announced today the U.S. Food and Drug Administration (FDA) approved a state-of-the-art drug product manufacturing hub in Parsippany, NJ, for its intravesical non-replicating ...

Diarrhea Diarrhea was the most common adverse reaction in two randomized, double-blind, placebo-controlled trials of IBS-C. Severe diarrhea was reported in 2.5% of IBSRELA-treated patients. If severe ...

You might live hundreds of miles away from your childhood home. You might be a parent, a manager, or a fully independent ...

Trump administration health officials announced Tuesday they hope to eliminate eight petroleum-based synthetic dyes from the nation’s food supply before the end of next year, though they haven’t ...